AFA
MEDP icon

Abacus FCF Advisors’s Medpace MEDP Stock Holding History

Abacus FCF Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.64M Buy
12,529
+196
+2% +$90.5K 1.22% 40
2026
Q1 		$5.92M Sell
12,333
-8,820
-42% -$4.52M 1.33% 38
2025
Q4 		$11.9M Buy
21,153
+490
+2% +$278K 1.55% 31
2025
Q3 		$10.6M Buy
20,663
+3,917
+23% +$1.71M 1.41% 35
2025
Q2 		$5.26M Buy
16,746
+287
+2% +$86.2K 0.74% 48
2025
Q1 		$5.01M Buy
16,459
+6,931
+73% +$2.33M 0.79% 41
2024
Q4 		$3.17M Buy
9,528
+2,976
+45% +$1.01M 0.42% 73
2024
Q3 		$2.19M Sell
6,552
-3,221
-33% -$1.22M 0.51% 77
2024
Q2 		$4.03M Buy
9,773
+4
+0% +$1.58K 1% 28
2024
Q1 		$3.95M Sell
9,769
-36
-0.4% -$12.7K 0.99% 28
2023
Q4 		$3.01M Buy
9,805
+4,356
+80% +$1.18M 0.87% 29
2023
Q3 		$1.32M Sell
5,449
-150
-3% -$38.4K 0.7% 45
2023
Q2 		$1.34M Sell
5,599
-36
-0.6% -$7.48K 0.68% 50
2023
Q1 		$1.06M Buy
5,635
+720
+15% +$149K 0.57% 68
2022
Q4 		$1.04M Sell
4,915
-108
-2% -$21.6K 0.68% 49
2022
Q3 		$789K Buy
+5,023
New +$802K 0.54% 80

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Abacus FCF Advisors's MEDP Position: Q2 2026 in Review

Abacus FCF Advisors increased its Medpace (MEDP) stake by 1.6% in Q2 2026, buying an estimated $90.5K and bringing the position to 12,529 shares worth $6.64M. The position accounts for 1.22% of the portfolio, ranked #40.

Abacus FCF Advisors first reported a position in MEDP in Q3 2022 and has held it in 16 quarters since. The position peaked at $11.9M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Abacus FCF Advisors held 12,529 shares of Medpace worth $6.64M as of Q2 2026.
  • Abacus FCF Advisors bought 196 Medpace shares in Q2 2026, an estimated $90.5K.
  • Medpace made up 1.22% of Abacus FCF Advisors's portfolio in Q2 2026, its #40 holding.
  • Abacus FCF Advisors first reported a position in Medpace in Q3 2022 and has held it in 16 quarters since.
  • Abacus FCF Advisors's Medpace position peaked at $11.9M in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Abacus FCF Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.